Pediatric T-lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation
Research output: Contribution to journal › Journal article › Research › peer-review
Relapsed precursor T-cell acute lymphoblastic leukemia is characterized by resistance against chemotherapy and is frequently fatal. We aimed at understanding the molecular mechanisms resulting in relapse of T-cell acute lymphoblastic leukemia and analyzed 13 patients at first diagnosis, remission and relapse by whole exome sequencing, targeted ultra-deep sequencing, multiplex ligation dependent probe amplification and DNA methylation array. In relapse compared to primary T-cell acute lymphoblastic leukemia, the number of single nucleotide variants and small insertions and deletions approximately doubled from 11.5 to 26. Targeted ultra-deep sequencing sensitively detected subclones that were selected for in relapse. The mutational pattern defined two types of relapses. While both are characterized by selection of subclones and acquisition of novel mutations, type 1 relapse derives from the primary leukemia whereas type 2 relapse originates from a common preleukemic ancestor. Relapse-specific changes included activation of the nucleotidase NT5C2 resulting in chemotherapy resistance and mutations of epigenetic modulators, exemplified by SUZ12, WHSC1 and SMARCA4. While mutations present in primary leukemia and in relapse were enriched for known drivers of leukemia, relapse-specific changes revealed an association to general cancer-promoting mechanisms. This study thus identifies mechanisms that drive progression of pediatric T-cell acute lymphoblastic leukemia to relapse and may explain the characteristic treatment resistance of this condition.
Original language | English |
---|---|
Article number | 100 |
Journal | Haematologica |
Pages (from-to) | 1442-1450 |
Number of pages | 8 |
ISSN | 0390-6078 |
DOIs | |
Publication status | Published - 20 Aug 2015 |
Externally published | Yes |
ID: 144838645